June 2012

BioMedix grant funds PAD testing

St. Paul, MN-based BioMedix, a healthcare information technology solutions provider, joined with the Western University of Health Sciences (WesternU) in May to promote amputation prevention through aware­ness and early detection of peripheral arterial disease (PAD).

BioMedix gave WesternU College of Podiatric Medicine in Pomona, CA, an educational grant that will give clinicians access to a user-friendly test for early detection of PAD. The 20-minute noninvasive PADnet Arterial test helps identify obstructive disease and determine whether medical or surgical treatment is necessary. PAD affects up to 12 million US adults and, overall, vascular disease results in about 100,000 amputations each year, according to the Amputee Coalition.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.